-
After Bluebird's 75% Gain In 2017, Analysts At BTIG Downgrade To Neutral
Friday, June 30, 2017 - 8:50am | 370Read More...Shares of bluebird bio Inc (NASDAQ: BLUE) have gained 75 percent since the start of 2017, which prompted analysts at BTIG to downgrade the biotech company at the forefront of fighting against cancer. BTIG's Dane Leone downgrades Bluebird's stock rating from Buy to Neutral as many of the bullish...
-
Bluebuird Bio Crashes Nearly 30%: What's Next?
Monday, December 7, 2015 - 11:53am | 1162Read More...Shares of bluebird bio Inc (NASDAQ: BLUE) plunged nearly 30 percent Monday morning. Bluebird reported mixed results from its ongoing studies at an industry conference. Matthew Harrison of Morgan Stanley acknowledged he "took a swing and missed," but other top Wall Street pros...
-
Sterne Agee's 2015 Predictions For Fintech And Payments Sector
Friday, January 9, 2015 - 9:47am | 344Read More...Thomas McCrohan of Sterne Agee published a report on Friday detailing his top 10 predictions within the Payments and Financial Technology sector. Below are the analyst's predictions: eBay Inc's (NASDAQ: EBAY) PayPal will launch an alternative banking product which may include a...
